Settlement for $7 billion approved over Roundup cancer claims

A $7 billion settlement was issued on Friday over agrochemical giant Bayer’s popular weedkiller Roundup, which plaintiffs claimed caused non-Hodgkin lymphoma.

Settlement for $7 billion approved over Roundup cancer claims

TL;DR

  • Bayer agreed to a $7 billion settlement regarding Roundup cancer claims.
  • The settlement addresses lawsuits alleging Roundup caused non-Hodgkin lymphoma.
  • Payments will be made to thousands of Americans over a 20-year period.
  • Bayer denies any wrongdoing and has modified Roundup for residential use.
  • The settlement comes after a Supreme Court ruling on state court lawsuits for cancer warnings.
  • Non-Hodgkin lymphoma is a cancer of the lymphatic system.
  • The EPA states Roundup's active ingredient, glyphosate, is not cancer-causing when used properly.